Carient Heart and Vascular
Manassas, Virginia, United States
Cardiologist in the Bull Run, Virginia
8100 Ashton Ave Suite 200, Manassas, VA 20109
About Carient Heart and Vascular
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Boehringer Ingelheim
2
Bayer
1
Boston Scientific Corporation
1
Brigham and Women's Hospital
1
CVRx, Inc.
1
Kowa Research Institute, Inc.
1
Clinical Trials at Carient Heart and Vascular
During the past decade, Carient Heart and Vascular conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
2016-08-01
2020-05-31
Completed
5,388
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
2018-01-05
2020-11-19
Completed
586
The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
2019-12-06
2020-12-21
Terminated
752
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
2020-06-26
2028-06-01
Recruiting
5,000
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Carient Heart and Vascular" #1 sponsor was "Amgen" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Bayer" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Brigham and Women's Hospital"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Carient Heart and Vascular"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Carient Heart and Vascular
According to Clinical.Site data, the most researched conditions in "Carient Heart and Vascular" are
"Heart Failure" (3 trials), "Myocardial Infarction" (2 trials), "ASCVD" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Carient Heart and Vascular" in a lesser frequency.
Clinical Trials Intervention Types at Carient Heart and Vascular
Most popular intervention types in "Carient Heart and Vascular" are "Drug" (4 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Carient Heart and Vascular
The vast majority of trials in "Carient Heart and Vascular" are
9 trials for "All" genders.
Clinical Trials Status at Carient Heart and Vascular
Currently, there are NaN active trials in "Carient Heart and Vascular".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Carient Heart and Vascular,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Carient Heart and Vascular, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".